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the cytoplasm of live cells green, Propidium iodide - stains the
nuclei of dead cells red) were used to determine in situ chon-
drocyte viability at 2.5 hours (controls) and 7 days. Percentage
cell death was quantiﬁed within three dimensional regions of in-
terest (ROI) reconstructed from serial ’z-sections’ (optical CLSM
sections with reference to the z-axis) of the long edge of the
rectangular blocks of articular cartilage. For z-sections acquired
parallel to the z-axis (imaging all zones within the full thickness
of cartilage), percentage cell death (PCDFT) was quantiﬁed at
100µm intervals from the articular surface downwards within a
ROI measuring 971 x 100 x 60µm3 (x-y-z axes, respectively).
For z- sections acquired perpendicular to the z-axis (imaging
only the superﬁcial zone below the articular surface), percentage
cell death (PCDSZ) was quantiﬁed within a ROI measuring 971 x
500 x 60µm3 (x-y-z axes, respectively).
Results: The mean thickness of the articular cartilage “on” and
“off” bone was 573.4 ± 25.3µm and 533.5 ± 23µm, respectively
(p=0.3). PCDFT suggested cell death was localised to the super-
ﬁcial zone (∼ ﬁrst 100µm from the articular surface) for Groups
A, B and C at 2.5 hours and 7 days (analysis of variance, p<0.05
for all comparisons). PCDSZ was similar for Groups A and B at
2.5 hours (controls, p>0.05, Tables 1 and 2).
Table 1. Increase in superﬁcial zone chondrocyte death with excision of sub-
chondral bone
Time Group PCDSZ ± standard error
2.5 hours Group A (off bone) 7.1±2.6
Group B (on bone) 4.7±0.6
7 days Group A (off bone) 25.8±3.6
Group B (on bone) 6.4±1.3
With alternate day media changes (Table 1), PCDSZ was sig-
niﬁcantly greater at 7 days for Group A compared to Group
B (p=0.003). There was a signiﬁcant increase in PCDSZ from
2.5 hours to 7 days for Group A (p=0.001) but not for Group
B (p=0.2). With no media changes (Table 2), PCDSZ was sig-
niﬁcantly lower at 7 days for Group C compared to Group A
(p=0.001), but similar to Group B (p=0.2). There was no signif-
icant increase in PCDSZ for Group C from 2.5 hours to 7 days
(p=0.1).
Conclusions: In bovine tissue, excision of subchondral bone
from articular cartilage results in chondrocyte death at 7 days
that occurs almost exclusively in the superﬁcial zone. However,
the presence of subchondral bone in the culture medium protects
against chondrocyte death. These data suggest that subchondral
bone may interact with articular cartilage via soluble mediator(s)
that can inﬂuence chondrocyte survival.
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Purpose: Previously, we demonstrated that alterations of mi-
tochondrial respiratory complexes III and V may contribute to
the progression of chondrocyte inﬂammation, up-regulating the
COX-2 enzyme but not the COX-1. However, the contribution
of mitochondrial dysfunction in the degradation of extracellular
matrix and the implication of stress inducing signals is not well
deﬁned. In this study, we have investigated the relationship be-
tween the dysfunction of mitochondrial respiratory chain (MRC)
and the inﬂammatory response in human normal chondrocytes,
the possible degradation of extracellular matrix, as well as the
implication of calcium efﬂux signals, ROS and NF-κB in this
process.
Methods: Human normal chondrocytes were isolated from car-
tilage obtained from autopsies without history of joint disease.
Antimycin A (AA) and oligomycin were employed to inhibit the
mitochondrial complexes III and V, respectively. N-acetyl cysteine
(NAC), Ruthenium Red (RR) and BAY 117085 were employed
as ROS, mitochondrial calcium exchange or NF-κB inhibitors,
respectively. PGE2 production was evaluated by ELISA. Flow cy-
tometry was used to study the mitochondrial calcium exchange
using Rhod 2-AM. Expressions of mRNA of MMPs were studied
by real time PCR.
Results: Firstly, we assesed the production of the inﬂamma-
tory mediator PGE2 in normal chondrocytes in the presence of
AA (40 µg/ml) and oligomycin (10µg/ml). AA and oligomycin
increased PGE2 after 24 hours of treatment (505.32±131.71
and 287.66±103.68 respectively vs basal 28.69±9.19 pg/50.000
cells, p<0.01). Secondly, pretreatment for 2 h with NAC 2mM or
RR 25µM decreased the effect of AA up to 59.83±5.05% and
49.24±6.67%, respectively vs basal 100%, p<0.01. Values for
oligomycin decreased up to 30.26±5.93% and 30.25±25.24%
vs basal 100%, p<0.01. Thirdly, we examined whether NF-?B is
required for this PGE2 production. BAY 117085 (5 µM) reduced
up to 23.50±5.26% the effect of AA and up to 35±8.48% the
effect of oligomycin in the production of PGE2 vs basal 100%,
p<0.01. Finally, when calcium efﬂux was evaluated, we found
that the dysfunction of complexes III and V, produced a release
of calcium from mitochondria in a time-dependent manner. After
2 h of treatment with AA or oligomycin, levels of positive cells
for mitochondrial calcium were 15.65±1.21% and 53.33±3.4%
vs 61.3±1.69%, respectively, p<0.01. Responses to blockers of
the mitochondrial calcium exchange indicated that ROS produc-
tion was mitochondrial calcium depedent. Also, treatment with
vitamin E, protected against AA and Oligomycin induced PGE2.
Moreover, as MMPs are enzymes related to extracellular matrix
degradation, we studied the mRNA expression of MMP-1, -3 and
-13. Oligomycin produced an increase of MMP-1 and -3 ratio
(633.87 and 557.32 vs basal 1). In addition to this, we observed
an up-regulation of mRNA of MMP-13 when the complex III didn’t
work properly (39.07 vs basal 1).
Conclusions: These results showed that a dysfunction of mito-
chondrial respiratory complexes III and V, induced an inﬂamma-
tory and a degradation response in human normal chondrocytes.
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Purpose: Hypertrophic differentiation of chondrocytes is an im-
portant feature in OA cartilage which is involved in extracellular
matrix mineralization. This study aimed to develop a new cul-
ture model for studying chondrocyte hypertrophic differentiation
in vitro
Methods: Articular OA chondrocytes were cultured for 28 days in
monolayer or in alginate beads in different culture medium (1%
Insulin Transferrin,Selenium and BSA, 2% Ultroser G or 10%
Fetal Bovine Serum). DNA was quantiﬁed by ﬂuorimetry. The ex-
pression of gene characteristics of chondrocyte phenotype (AGG,
COL2A1, SOX9), pre-hypertrophic differentiation (ihh, PTH-R,
PTHrP), hypertrophic differentiation (COL10A1, cbfa1), matrix
mineralization (Ank, ENPP1, CILP, TG2, FXIIIA) or vasculariza-
tion (VEGF) was evaluated by RT-PCR. Alkaline phosphatase
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Figure 1. Expression of genes and enzymatic activities of chondrocytes after 21
days of culture in 10% FBS media, n=3.
activity, transglutaminase activity and 5’ phosphodiesterase ac-
tivity of NTPPPH were quantiﬁed by speciﬁc enzymatic methods
Results: In 10% FBS, chondrocytes expressed signiﬁcantly more
hypertrophic (PTH-R, PTHrP, ihh, COL10A1 and cbfa1) and ma-
trix mineralization genes (TG2, FXIIIA, CILP, ENPP1 and Ank)
in alginate beads than in monolayer (Figure 1). Whatever the
culture system (alginate beads or monolayer), chondrocytes cul-
tured in 10% FBS expressed signiﬁcantly more hypertrophic and
matrix mineralization genes like COL10A1 than chondrocytes
cultured in 1% ITS+ or 2% UG (Figure 2).
Figure 2. Expression of genes and enzymatic activities of chondrocytes after 21
days of culture in alginate beads, n=3.
Conclusions: The expression of hypertrophic markers in artic-
ular chondrocytes is upregulated in fetal bovine serum (FBS)
and alginate beads culture conditions, suggesting that cartilage
neovascularization could be a factor of chondrocyte hypertrophic
differentiation in OA cartilage
186
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Purpose: Primary human chondrocytes are difﬁcult to obtain,
and their gene expression and response to cytokine stimuli
are often inconsistent from donor to donor since factors such
as disease severity and donor age are complicating variables.
Therefore, immortalized chondrocyte-based cell lines are tempt-
ing alternatives for use in cell-based assays. However, these cell
lines are phenotypically different from the primary chondrocytes
(more ﬁbroblast-like, minimal extracellular matrix secretion) and
a limited molecular characterization has revealed some differ-
ences (Finger et al., 2003), yet no extensive analysis has been
performed previously.
Methods: In order to investigate in detail the similarities and
differences between primary chondrocytes and the chondrocytic
cell lines T/C-28a2, C-28/I2 and SW1353, cells were treated in
monolayer culture with or without IL-1 (1ng/ml) or TNF (10ng/ml)
for 18 hours and global transcriptional changes were studied
using Affymetrix gene chips. Focused gene expression was also
analyzed using a TaqMan Low Density Array (TLDA) Immune
Panel from Applied Biosystems, which measures the transcrip-
tional levels of 90 immune- and inﬂammation-related genes si-
multaneously.
Results: Global proﬁling using correlation maps and hierarchical
clustering indicated that transcriptional patterns in T/C-28a2, C-
28/I2 and SW1353 are signiﬁcantly different than in the primary
chondrocytes. The transcriptional patterns of these samples clus-
tered more closely to ﬁbroblastic cell lines, such as BJ cells, than
to the primary chondrocytes. The magnitude of transcriptional
response to cytokines by primary chondrocytes was generally
more than 10 fold greater than that of the immortalized cell lines.
Transcriptional proﬁles of the chondrocyte cell lines T/C-28a2
and C-28/I2 were also signiﬁcantly different from each other, and
genes that were differentially expressed in the two cell lines were
identiﬁed. Clustering analysis, Welch t-tests, as well as compar-
ison of selected chondrocyte-speciﬁc gene expression patterns
showed that the T/C-28a2 cell line is more similar to the human
primary chondrocytes than the C-28/I2 line. Cytokine responsive
gene sets common to all of the cells as well as gene sets unique
to each cell type were identiﬁed for both IL-1 and TNF. Finally,
TLDA analysis of immune related gene expression allowed de-
tection of gene expression that was not measurable by gene chip
analysis due to its lower sensitivity.
Conclusions: Our transcriptional analysis study using gene chip
and TLDA showed that the immortalized chondrocytes (and
SW1353 chondrosarcoma cells) that are frequently used in car-
tilage research are signiﬁcantly different from primary chondro-
cytes. These results should be taken into consideration before
choosing these cells as a substitute for primary chondrocytes in
in vitro experiments.
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Purpose: The articular chondrocyte is responsible for both ma-
trix production and destruction. Excessive collagen II degradation
is accompanied by loss of aggrecan in osteoarthritis (OA). Col-
lagen II breakdown is mediated primarily by collagenases while
aggrecan degradation is dependent on the activation of matrix
metalloproteinases (MMPs) and aggrecanases. We have recently
shown that the CO-releasing molecule tricarbonyldichlororuthe-
nium(II) (CORM-2) inhibits aggrecan degradation in OA cartilage
explants. The objective of this work was to investigate the ef-
fects of CORM-2 on extracellular matrix components and the
mechanisms involved.
Methods: Cartilage specimens were obtained from 15 patients
with diagnosis of advanced OA undergoing total knee joint re-
